POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953
POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953
| Release | Change | Old | New |
|---|---|---|---|
| July 2026 | Fee ↑ | $139.85 | $143.5 |
Data sourced from Australian Government publications · Not an official government service